Beijing, China

Chunmei Xue

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Beijing Increase Innovative Drug Co., Ltd. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chunmei Xue. Retrieved from https://idiyas.com/inventor/chunmei-xue

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovative Contributions of Inventor Chunmei Xue**

Introduction

Chunmei Xue is an accomplished inventor based in Beijing, China, recognized for her significant contributions to the field of biomedical innovation. With a focus on developing therapies that enhance vascular health, she has made strides in providing safer and more effective treatments.

Latest Patents

Chunmei Xue holds a patent titled "Rho kinase inhibitor, method for preparing same and uses thereof." This invention encompasses a Rho kinase inhibitor, which is designed to promote the expression of endothelial cells and various vascular factors. The compound is characterized by its low toxicity and safer profile, providing a promising avenue for therapeutic applications in cardiovascular health.

Career Highlights

At Beijing Increase Innovative Drug Co., Ltd., Chunmei serves as a vital part of the research and development team. Her work on the Rho kinase inhibitor has positioned her as a key player in the pursuit of innovative treatments in the pharmaceutical landscape.

Collaborations

Chunmei collaborates with talented professionals such as Baoxian Zhang and Hongwu Zhang, harnessing their combined expertise to drive forward their projects. Together, they are focused on enhancing the efficacy and safety of new drugs aimed at addressing cardiovascular conditions.

Conclusion

Chunmei Xue’s innovative work in developing Rho kinase inhibitors exemplifies her dedication to improving healthcare outcomes. Her contributions not only advance scientific knowledge but also hold the potential to significantly impact the treatment of vascular diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…